JANSSEN PHARMACEUTICALS, INC. v. BECERRA et al
Case Number:
3:23-cv-03818
Court:
Nature of Suit:
Judge:
Firms
- Akin Gump
- Buttaci Leardi
- Carella Byrne
- Chiesa Shahinian
- Covington & Burling
- Flitter Milz
- Green Savits
- Lieff Cabraser
- Miller Shah LLP
- Robinson Miller
- Weissman & Mintz
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Fresenius Kabi AG
- Fresenius SE & Co. KGaA
- Public Citizen Inc.
Government Agencies
Sectors & Industries:
-
July 21, 2023
The Litigation Jolting Health & Life Sciences In 2023's 2nd Half
A head-spinning spree of rulings and new lawsuits in 2023's first half is reverberating across the health care industry and auguring a dizzying denouement in the year's final months that may well upend assumptions about drug prices and approvals, the False Claims Act and the powers of federal regulators.
-
July 18, 2023
J&J Unit Launches 6th Challenge To Drug Price Negotiations
Johnson & Johnson unit Janssen Pharmaceuticals has launched a suit to challenge a system allowing Medicare to negotiate prescription drug prices under a federal inflation deterrent, marking at least the sixth lawsuit to fight the provision.
- ← Previous
- 1
- 2
- Next →